Uretal Flow Assessment During Gynecological Procedures
Launched by ETHICON, INC. · Mar 28, 2007
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Meets criteria for conservative gynecological procedure
- • At least 25 years of age
- • Cervix suitable for tenaculum placement
- • Provides written informed consent.
- Exclusion Criteria:
- • Pregnancy
- • One or more lower uterine segment fibroids
- • Hydronephrosis as determined by renal ultrasound pre-procedurally
- • Clinical diagnosis of urinary tract infection (UTI)
- • In the medical judgment of the physician, such a procedure may compromise the patient's condition
- • Inability to achieve bilateral occlusion with the clamp placement during the procedure.
About Ethicon, Inc.
Ethicon, Inc., a subsidiary of Johnson & Johnson, is a leading global innovator in surgical products and technologies, dedicated to advancing surgical care through research and development. With a focus on enhancing patient outcomes, Ethicon specializes in the design and manufacturing of sutures, staplers, and minimally invasive surgical instruments, as well as wound care solutions. The company is committed to conducting clinical trials that evaluate the safety and efficacy of its products, ensuring adherence to the highest standards of quality and regulatory compliance. Ethicon's ongoing collaboration with healthcare professionals and institutions aims to drive medical breakthroughs and improve the overall effectiveness of surgical procedures.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort Lauderdale, Florida, United States
Patients applied
Trial Officials
David Robinson, MD
Study Director
Ethicon, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials